Pulmatrix Announces Presentations at ATS 2012 International Conference  
5/16/2012 10:15:11 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced that six posters on its iCALM™ and iSPERSE™ inhaled drug platforms have been selected for presentation at the American Thoracic Society (ATS) 2012 International Conference taking place May 18-23, 2012, in San Francisco, CA.